On October 12, the Food and Drug Administration (FDA) authorized the first-ever vaping product to legally be sold in the United States.

The FDA determined that the Vuse Solo, along with two “tobacco”-flavored e-liquid cartridges, were “appropriate for the protection of public health”—meaning the agency believed that the products were more likely to help adult smokers switch to a safer alternative than to introduce a new generation to nicotine.

The decision is historic, but leaves advocates on both sides of the raging vaping debate dissatisfied.

“Today’s authorizations are an important step toward ensuring all new tobacco products undergo the FDA’s robust, scientific premarket evaluation,” Mitch Zeller, the director of the FDA’s Center for Tobacco Products (CTP), said in a press statement. “The manufacturer’s data demonstrates its tobacco-flavored products could benefit addicted adult smokers who switch to these products—either completely or with a significant reduction in cigarette consumption—by reducing their exposure to harmful chemicals.”

Read full article here.

Alex Norcia – Filter – 2021-10-13.

Want More Investigative Content?

LEAVE A REPLY

Please enter your comment!
Please enter your name here